- Home
- FBIOP vs EICC Comparison
FBIOP vs EICC Comparison
Compare FBIOP & EICC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- EICC
- Stock Information
- Founded
- FBIOP N/A
- EICC N/A
- Country
- FBIOP United States
- EICC
- Employees
- FBIOP 186
- EICC N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- EICC
- Sector
- FBIOP Health Care
- EICC
- Exchange
- FBIOP Nasdaq
- EICC Nasdaq
- Market Cap
- FBIOP N/A
- EICC N/A
- IPO Year
- FBIOP N/A
- EICC N/A
- Fundamental
- Price
- FBIOP $5.08
- EICC $25.17
- Analyst Decision
- FBIOP
- EICC
- Analyst Count
- FBIOP 0
- EICC 0
- Target Price
- FBIOP N/A
- EICC N/A
- AVG Volume (30 Days)
- FBIOP N/A
- EICC N/A
- Earning Date
- FBIOP N/A
- EICC N/A
- Dividend Yield
- FBIOP N/A
- EICC N/A
- EPS Growth
- FBIOP N/A
- EICC N/A
- EPS
- FBIOP N/A
- EICC N/A
- Revenue
- FBIOP N/A
- EICC N/A
- Revenue This Year
- FBIOP N/A
- EICC N/A
- Revenue Next Year
- FBIOP N/A
- EICC N/A
- P/E Ratio
- FBIOP N/A
- EICC N/A
- Revenue Growth
- FBIOP N/A
- EICC N/A
- 52 Week Low
- FBIOP N/A
- EICC N/A
- 52 Week High
- FBIOP N/A
- EICC N/A
- Technical
- Relative Strength Index (RSI)
- FBIOP 49.96
- EICC N/A
- Support Level
- FBIOP $5.01
- EICC N/A
- Resistance Level
- FBIOP $5.86
- EICC N/A
- Average True Range (ATR)
- FBIOP 0.51
- EICC 0.00
- MACD
- FBIOP -0.03
- EICC 0.00
- Stochastic Oscillator
- FBIOP 28.99
- EICC 0.00
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
About EICC Eagle Point Income Company Inc. 8.00% Series C Term Preferred Stock due 2029
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.